Yanwen Lu

555 total citations
33 papers, 372 citations indexed

About

Yanwen Lu is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Electrical and Electronic Engineering. According to data from OpenAlex, Yanwen Lu has authored 33 papers receiving a total of 372 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 9 papers in Pulmonary and Respiratory Medicine and 6 papers in Electrical and Electronic Engineering. Recurrent topics in Yanwen Lu's work include Renal cell carcinoma treatment (5 papers), Renal and related cancers (5 papers) and Ferroptosis and cancer prognosis (4 papers). Yanwen Lu is often cited by papers focused on Renal cell carcinoma treatment (5 papers), Renal and related cancers (5 papers) and Ferroptosis and cancer prognosis (4 papers). Yanwen Lu collaborates with scholars based in China, South Korea and Malaysia. Yanwen Lu's co-authors include Yuefeng Tang, Wenliang Ma, Dongmei Li, Lei Yang, Liang Ni, Weidong Gan, Yanbin Chen, Yi Chen, Ning Liu and Haiming Li and has published in prestigious journals such as Journal of Power Sources, Scientific Reports and Journal of the American Society of Nephrology.

In The Last Decade

Yanwen Lu

31 papers receiving 365 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yanwen Lu China 13 135 134 62 60 49 33 372
Priscila Calle Spain 7 102 0.8× 116 0.9× 23 0.4× 32 0.5× 17 0.3× 13 382
Juan Zou China 13 84 0.6× 171 1.3× 18 0.3× 106 1.8× 5 0.1× 28 523
Jaehee Kim South Korea 12 42 0.3× 198 1.5× 29 0.5× 32 0.5× 9 0.2× 29 422
Ji Young Kim South Korea 12 166 1.2× 45 0.3× 34 0.5× 18 0.3× 4 0.1× 15 412
Xing Hu China 10 60 0.4× 45 0.3× 9 0.1× 17 0.3× 6 0.1× 51 303
B. Li China 7 65 0.5× 40 0.3× 14 0.2× 35 0.6× 31 0.6× 19 230
Xihao Li United States 11 94 0.7× 124 0.9× 46 0.7× 45 0.8× 25 0.5× 24 456
Zhenwang Zhang China 12 54 0.4× 127 0.9× 2 0.0× 30 0.5× 5 0.1× 40 289
Shun He China 15 39 0.3× 226 1.7× 14 0.2× 121 2.0× 12 0.2× 78 660
Yuming Zou China 9 46 0.3× 78 0.6× 7 0.1× 14 0.2× 4 0.1× 12 320

Countries citing papers authored by Yanwen Lu

Since Specialization
Citations

This map shows the geographic impact of Yanwen Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanwen Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanwen Lu more than expected).

Fields of papers citing papers by Yanwen Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yanwen Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanwen Lu. The network helps show where Yanwen Lu may publish in the future.

Co-authorship network of co-authors of Yanwen Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Yanwen Lu. A scholar is included among the top collaborators of Yanwen Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yanwen Lu. Yanwen Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lu, Yanwen, et al.. (2025). Exploring the potential value of SRC in pan cancer based on bioinformatics methods. Discover Oncology. 16(1). 1309–1309.
2.
Ma, Wenliang, Yi Chen, Lei Yang, et al.. (2025). TFE3 fusion proteins promote the progression of TFE3 rearranged renal cell carcinoma via enhancing chaperone-mediated lipophagy. Cell Communication and Signaling. 23(1). 122–122.
3.
4.
5.
Chen, Yi, Yanwen Lu, Lei Yang, et al.. (2023). LncRNA like NMRK2 mRNA functions as a key molecular scaffold to enhance mitochondrial respiration of NONO-TFE3 rearranged renal cell carcinoma in an NAD+ kinase-independent manner. Journal of Experimental & Clinical Cancer Research. 42(1). 252–252. 9 indexed citations
6.
Zhou, Shuoming, Yanwen Lu, Yuxin Chen, & Weidong Gan. (2023). Identification of an immunogenic cell death-related gene signature predicts survival and sensitivity to immunotherapy in clear cell renal carcinoma. Scientific Reports. 13(1). 4449–4449. 2 indexed citations
7.
Lu, Yanwen, Wenliang Ma, Ning Liu, et al.. (2023). Estrogen associates with female predominance in Xp11.2 translocation renal cell carcinoma. Scientific Reports. 13(1). 6141–6141. 1 indexed citations
8.
Lu, Yanwen, et al.. (2023). Differentiate Xp11.2 Translocation Renal Cell Carcinoma from Computed Tomography Images and Clinical Data with ResNet-18 CNN and XGBoost. Computer Modeling in Engineering & Sciences. 136(1). 347–362. 3 indexed citations
9.
Ling, Rongsong, Gan Xiong, Yanwen Lu, et al.. (2023). Single-cell transcriptomic analysis uncovers the origin and intratumoral heterogeneity of parotid pleomorphic adenoma. International Journal of Oral Science. 15(1). 38–38. 11 indexed citations
10.
Ma, Wenliang, Haifeng Huang, Wei Wang, et al.. (2022). Contrast‐Enhanced Ultrasound Features of Adult Xp11.2 Translocation Renal Cell Carcinoma. Journal of Ultrasound in Medicine. 41(11). 2673–2685. 4 indexed citations
11.
Liu, Ning, Yi Chen, Lei Yang, et al.. (2022). Both SUMOylation and ubiquitination of TFE3 fusion protein regulated by androgen receptor are the potential target in the therapy of Xp11.2 translocation renal cell carcinoma. Clinical and Translational Medicine. 12(4). e797–e797. 7 indexed citations
12.
Chen, Yi, Lei Yang, Yanwen Lu, et al.. (2022). Up-regulation of NMRK2 mediated by TFE3 fusions is the key for energy metabolism adaption of Xp11.2 translocation renal cell carcinoma. Cancer Letters. 538. 215689–215689. 16 indexed citations
13.
Yang, Lei, Yi Chen, Ning Liu, et al.. (2022). CircMET promotes tumor proliferation by enhancing CDKN2A mRNA decay and upregulating SMAD3. Molecular Cancer. 21(1). 23–23. 44 indexed citations
14.
Yang, Lei, Yi Chen, Chun Pan, et al.. (2022). Low expression of PEBP1P2 promotes metastasis of clear cell renal cell carcinoma by post-transcriptional regulation of PEBP1 and KLF13 mRNA. Experimental Hematology and Oncology. 11(1). 87–87. 12 indexed citations
15.
Yang, Lei, Yi Chen, Ning Liu, et al.. (2022). 5mC and H3K9me3 of TRAF3IP2 promoter region accelerates the progression of translocation renal cell carcinoma. Biomarker Research. 10(1). 54–54. 12 indexed citations
16.
Chen, Rui, Wei Pan, Ziyu Liu, et al.. (2022). Effects of serum branched-chain amino acids on nonalcoholic fatty liver disease and subsequent cardiovascular disease. Hepatology International. 16(6). 1424–1434. 12 indexed citations
17.
Liu, Jing, et al.. (2020). Study on the spatial distribution characteristics of urban innovation power in Yangtze River Delta urban agglomeration. IOP Conference Series Earth and Environmental Science. 474(5). 52070–52070. 3 indexed citations
18.
Ni, Liang, et al.. (2015). High-performance, nanostructure LiMnPO4/C composites synthesized via one-step solid state reaction. Journal of Power Sources. 282. 444–451. 42 indexed citations
19.
Zhang, Qian, Haiming Li, Yanwen Lu, et al.. (2011). Cyclooxygenase 2 Promotes Parathyroid Hyperplasia in ESRD. Journal of the American Society of Nephrology. 22(4). 664–672. 21 indexed citations
20.
Zhang, Qian, Ming Li, Yanwen Lu, et al.. (2010). Meta-Analysis Comparing Sevelamer and Calcium-Based Phosphate Binders on Cardiovascular Calcification in Hemodialysis Patients. Nephron Clinical Practice. 115(4). c259–c267. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Priscila Calle Breakdown of academic impact, for papers by Juan Zou Breakdown of academic impact, for papers by Jaehee Kim Breakdown of academic impact, for papers by Ji Young Kim Breakdown of academic impact, for papers by Xing Hu Breakdown of academic impact, for papers by B. Li Breakdown of academic impact, for papers by Xihao Li Breakdown of academic impact, for papers by Zhenwang Zhang Breakdown of academic impact, for papers by Shun He Breakdown of academic impact, for papers by Yuming Zou
Rankless by CCL
2026